Study S000902

A Single-center, Open-label, Fixed-sequence, Self-controlled Pharmacokinetics Study of Metformin and HRS-7535 in Healthy Subjects

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06727838
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 18
Start: 2024-12-31
Primary completion: 2025-01-25
Lead sponsor: Shandong Suncadia Medicine Co., Ltd.
Conditions: Diabetes
Interventions: DRUG:HRS-7535 tablets; DRUG:Metformin Hydrochloride Extended-release Tablets; DRUG:Metformin Hydrochloride Tablets
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Maximum plasma concentration (Cmax) [0 hour to 24 hours after the last dosing.]
Area under the plasma concentration-time curve from time zero to the time of last quantifiable analyte concentration (AUC0-t) [0 hour to 24 hours after the last dosing.]
Area under the plasma concentration-time curve from time zero extrapolated to infinity (AUC0-∞) [0 hour to 24 hours after the last dosing.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.